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1. Introduction 
The anti-neoplastic enzyme L-asparaginase inhibits 
the growth of certain malignant cells by interference 
with cell nutrition [ 1,2] . We have recently reported 
[3] that Lasparaginase inhibits the incorporation of 
labeled L-fucose and D-glucosamine into glycoproteins 
of L5 178Y murine leukemia cells. Three questions 
arise with respect o this finding: 1) Is the inhibition 
of glycoprotein synthesis aconsequence of a general 
inhibition of all protein formation? 2) Can the ob- 
served results be explained on the basis of the known 
glutaminase activity [4] of asparaginase preparations? 
3) Is glycoprotein formation inhibited by L-asparagi- 
nase in cell lines resistant to the anti-neoplastic action 
of the enzyme? In the present study, we have provided 
evidence to indicate that L-asparaginase preferentially 
inhibits glycoprotein formation in asparaginase-sensi- 
tive cell lines in a manner unrelated to the glutaminase 
activity of the enzyme. 
For this study, we have employed the L5 178Y 
murine leukemia, which has an absolute requirement 
for L-asparagine, in culture [5] , and a subline, 
L5 178Y/ASP, derived from L5 178Y by selection for 
asparaginase resistance. Incorporation of labeled L 
leucine, L-fucose and D-glucosamine into protein and 
glycoprotein was measured, and the inhibitory effects 
of L-asparaginase w re compared with those of cyclo- 
heximide, a potent inhibitor of protein synthesis [6]. 
LAsparaginase inhibited incorporation of fucose 
and glucosamine into L5 178Y glycoproteins as rapid- 
ly as did cycloheximide, but inhibited incorporation 
of leucine into proteins less rapidly than cyclohexi- 
mide. The inhibitory action of the enzyme was not 
related to contaminating glutaminase activity, during 
short-term incubations. Asparaginase did not effect 
protein and glycoprotein formation by L5 178Y/ASP 
cells, except at very high enzyme levels. 
2. Materials and methods 
The L5 178Y and L5 178Y/ASP cell lines were 
provided by Mr. I. Wodinsky, Arthur D. Little Inc., 
Cambridge, Massachusetts. The latter cell line was 
derived from L5 178Y by selection for resistance to 
100 I.U./kg of L-asparaginase in wiw. Both cell lines 
were carried in CDF, mice by weekly transplant of 
IO6 cells. 
LAsparaginase (360 U./mg) was obtained from 
the National Cancer Institute, and was manufactured 
by Merck, Sharpe and Dohme, Inc. L-Leucine-l-14C, 
D-glucosamine-U-14C, L-fucose-U3H, L-asparagine- 
4-14C and L-glutamine-U-14C were purchased from 
New England Nuclear Corp., cycloheximide (crystal- 
line) from Mann Research Laboratories, Fischer’s 
medium (10 X) from Grand Island Biological Col, 
and N-hydroxyethylpiperazine-N’-2ethanesulfonic 
acid (HEPES) buffer from Calbiochem Corp. 
Cells were removed from animals on day seven 
after transplant, and were collected in cold 0.9% 
NaCl. Erythrocytes were removed by osmotic shock, 
and the cells were washed with HEPES-buffered 
saline 171. The cells were suspended in modified 
Fischer’s medium [8] with 7.65 g/l HEPES replacing 
the NaHCO, . The suspension, which contained 
500 mg of cells (wet weight) per 10 ml, was filtered 
through Miracloth (Calbiochem Corp.). 
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Cell suspensions were incubated in the modified 
Fischer’s medium containing specified levels of cyclo- 
heximide, L-asparaginase and radioactive precursors, 
at 37”, with occasional shaking. At intervals, 0.2 ml 
portions of the suspension were removed, quickly 
chilled and the cells collected by centrifugation at 
250 g for 40 sec. The resulting pellets were resuspend- 
ed in 1 ml of cold 5% trichloroacetic acid, and the 
cells were collected, by centrifugation, after 3 min. 
After two more acid washes and one ether-ethanol 
(1:2, v/v) wash the precipitate was washed with 
water, and dispersed in 50 ~1 of water + 450 ~1 of 
Nuclear Chicago Solubilizer (NCS). After solution 
was complete, a 400 /.d portion of this mixture was 
diluted with 10 ml of a toluene-based liquid phosphor 
for measurement of radioactivity by liquid scintilla- 
tion counting. After incorporation and hydrolysis, 
the labeled material in the case of L-leucine-1 -14C 
was 100% leucine; the fucose-U3H, 100% fucose; 
and the glucosamine, 70% glucosamine, 20% galac- 
tosamine and 10% N-acetylneuraminic a id [3] . 
Incubation mixtures contained IO mg/l of L- 
asparagine or 200 mg/l of glutamine, levels which 
are found in Fischer’s medium [8] . Tracer levels of 
labeled L-asparaglne or L-glutamine were added. 
Total incubation volumes were 200 fl. At intervals, 
10 1.11 portions were removed, and subjected to elec- 
trophoretic separation i  0.05 M barbital buffer at 
pH 8. Carrier amino acids were added to facilitate 
identification of the appropriate spots by the ninhy- 
drin color reaction. The spots were removed from the 
paper, and radioactivity was determined by liquid 
scintillation counting. 
3. Results and discussion 
Cell suspensions were mixed with 0.02-200 
U./ml of L-asparaginase and warmed to 37’. After 
5 min, labeled L-leucine (final level = 200 W), D- 
glucosamine (10 PM) or L-fucose (1 PM) was added. 
Cell samples were taken at 0, lo,20 and 30 min 
after addition of radioactive precursors. Incorpora- 
tion of radioactivity into the acid-insoluble fractions 
represented incorporation of leucine into protein, and 
of fucose and glucosamine into glycoprotein [3]. The 
rate of such incorporation proceeded linearly for at 
least 20 min in control assay. The data of fig. 1 repre- 
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Fig. 1. Glycoprotein and protein synthesis by LS 178Y and 
LS 178Y/ASP cells. Levels of L-asparaginase in the medium 
are specified. The data indicate relative incorporation of leu- 
tine and glucosamine over a 20 min interval. The rates of 
loss of glutamine (GLN) and asparagine (ASN) from the 
medium as function of the L-asparaginase concentration, are 
also shown. 
sent inhibition of leucine and glucosamine incorpora- 
tion as a function of the L-asparaginase concentration. 
Experiments utilizing L-fucose yielded data similar to 
that obtained with glucosamine. Precursor incorpora- 
tion into L.5 178Y cells was profoundly inhibited, 
even by 0.02 U./ml levels of the enzyme. Higher 
levels produced some additional inhibition. In con- 
trast , precursor incorporation in L5 178Y/ASP was 
unaffected until enzyme levels reached 200 U./ml. 
The rates of hydrolysis of L-asparagine and L- 
glutamine in Fischer’s medium were measured, and 
the time required for loss of 50% of the initial levels 
of these amino acids is shown, in fig. 1, as a function 
of the L-asparaginase level. The data indicate that in- 
hibition by L-asparaginase of leucine and glucosamine 
incorporation over a 20 min interval is not related to 
removal of glutamine from the medium. 
In other studies, we found that omission of gluta- 
mine from Fischer’s medium did not inhibit the in- 
corporation of glucosamine or leucine into macro- 
molecules in L5 178Y or L5 178Y/ASP cells under 
conditions pecified above. 
Incorporation of leucine and glucosamine by 
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Fig. 2. Glycoprotein and protein synthesis by L5178Y and 
LS 178Y/ASP cells. Cells were incubated with 2 U./ml of L- 
asparaginase (A), 10 pgfml of cycloheximide (o) or with 
neither (o), along with labeled leucine or fucose, as described 
in the text. Results are expressed relative to the 40 min con- 
trol value, taken as 100%. 
L5 178Y/ASP cells was affected at 200 U./ml of L- 
asparaginase. This might be related to the capacity [3] 
of high levels of this enzyme to cleave the glycopep- 
tide bond between carbohydrate and the amide ni- 
trogen of L-asparagine found in certain glycoproteins 
[9] . Alternatively, use of such high concentrations of 
the enzyme may cause the enzyme to enter the intra- 
cellular space and act on intracellular asparagine pools. 
In another study, L5178Y cell suspensions were 
incubated with labeled precursors together with 10 
fig/ml of cycloheximide or 2 U./ml of asparaginase. 
This level of cycloheximide was the minimum which 
promptly stopped incorporation of leucine into pro- 
tein. Incorporation of precursors into an acid-insoluble 
fraction was measured. The results (fig. 2) show that 
cycloheximide abolished leucine incorporation at once, 
but that leucine incorporation continued for a short 
time in the presence of asparaginase. Presumably, pro- 
teins not containing asparagine were formed, together 
with some proteins utilizing endogenous stores of 
this amino acid. Fucose incorporation was inhibited 
at approximately equal rates by cycloheximide or as- 
paraginase. These results were not changed when 
glucosamine was employed as the glycoprotein pre- 
cursor. The combination of asparaginase + cyclohexi- 
mide was not more effective than cycloheximide 
alone. These data suggest that considerable incorpo- 
ration of leucine but not of fucose into cyclohexi- 
mide-inhibitable protein continues after administra- 
tion of asparaginase to L5 178Y cells. 
These studies were repeated, using the L5178Y/ASP 
cell line as a control. L-asparaginase did not inhibit 
incorporation of either fucose or leucine into macro- 
molecules, at 2 U./ml (fig. 2). 
We conclude that L-asparaginase inhibits a cyclo- 
heximidesensitive incorporation of fucose into glyco- 
protein more rapidly than the enzyme inhibits cyclo- 
heximide-sensitive leucine incorporation into protein. 
Over short time periods, this inhibition is not related 
to glutaminase activity of asparaginase preparations. 
The latter enzyme inhibited neither protein nor glyco- 
protein in an asparaginase-resistant cell line, except at 
very high asparaginase levels. Although interference 
with glycoprotein synthesis would be expected as a 
result of a general inhibition of protein formation 
[ 1,2] , a preferential early inhibition of glycoprotein 
formation could explain the rapid dissolution of cell 
membranes caused by Lasparaginase [lo] . 
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